Mickael Hiligsmann presented at the World Congress of Osteoporosis 2019

Mickael Hiligsmann co-chaired three symposiums and was speaker at four symposiums during the World Congress of Osteoporosis (WCO-ESCEO-IOF) that was held in Paris between 3 and 6 April 2019.

Mickael Hiligsmann

The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a not-for-profit organization, dedicated to a close interaction between clinical scientists dealing with bone, joint and muscle disorder, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of Osteoporosis and Osteoarthritis within the comprehensive perspective of health resources utilization.

The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. – www.esceo.org

Mickael Hiligsmann was invited to chair and speak during  the symposium “Selection of relevant outcome in sarcopenia: a discrete-choice experiment” organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) during the International Conference on Frailty & Sarcopenia Research in Miami Beach, USA, on February 22nd, 2019. More information.

Also read